MetaCap

Albemarle (ALB) vs Balchem (BCPC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Balchem (BCPC) has outperformed Albemarle (ALB) over the past year, gaining 5.2% versus a loss of 31.8%. Over five years, BCPC leads with a -1.1% price change compared with -70.1% for ALB. Albemarle is the larger company by market cap ($9.41 billion vs $5.20 billion), about 1.8 times the size, while Balchem is growing revenue faster (+8.8% vs -4.4%).

On valuation, Albemarle trades at a lower forward P/E (10.4x vs 25.7x for Balchem). Albemarle offers the higher dividend yield (2.04% vs 0.59%). Balchem converts more of its revenue into profit, with a net margin of 14.9% versus -9.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALB-31.78%BCPC+5.20%
+90%+26%-38%
Nov 21, 20251 yearNov 20, 2026
ALB-71.68%BCPC-2.32%
+20%-33%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALB versus BCPC key metrics
MetricALBBCPC
Share price$79.70$163.54
Market cap$9.41B$5.20B
1-day change-3.89%-1.21%
YTD return-43.65%+6.64%
1-year return-31.78%+5.20%
5-year return-70.13%-1.05%
P/E ratio (TTM)19.2030.86
Forward P/E10.4025.70
EPS (TTM)$4.15$5.30
Dividend yield2.04%0.59%
Annual dividend$1.63$0.96
Revenue (latest FY)$5.14B$1.04B
Revenue growth (YoY)-4.37%+8.75%
Net income (latest FY)$-510.63M$154.84M
Gross margin13.00%35.74%
Operating margin-7.14%20.18%
Net margin-9.93%14.93%
52-week high$221.00$186.15
52-week low$79.38$147.18
Distance from 52-week high-63.94%-12.15%
Analyst consensusbuynone
Avg. price target upside+76.35%+30.55%
Average volume2.44M252.38K
Shares outstanding118.01M31.78M
Employees7,8001,430
SectorIndustrialsIndustrials
IndustryMajor ChemicalsMajor Chemicals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BCPC has outperformed ALB by 37.0 percentage points over the past year.
  • Balchem trades at a higher earnings multiple (30.9x vs 19.2x trailing P/E).
  • Albemarle offers a meaningfully higher dividend yield (2.04% vs 0.59%).
  • Balchem is more profitable, keeping 14.9 cents of every revenue dollar as net income versus -9.9 cents for Albemarle.
  • Balchem grew revenue faster in its latest fiscal year (+8.75% vs -4.37%).

About Albemarle

ALB stock →

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen.

Industrials · Major Chemicals · 7,800 employees

About Balchem

BCPC stock →

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Industrials · Major Chemicals · 1,430 employees

ALB vs BCPC FAQ

Which is bigger, Albemarle or Balchem?

Albemarle (ALB) is larger, with a market capitalization of $9.41B compared with $5.20B for Balchem (BCPC).

Which stock has performed better over the past year, ALB or BCPC?

BCPC returned +5.20% over the past 12 months, compared with -31.78% for ALB (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ALB or BCPC?

ALB has the lower trailing P/E at 19.2, versus 30.9 for BCPC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Albemarle or Balchem?

Albemarle has the higher yield at 2.04%, compared with 0.59% for Balchem.

Are Albemarle and Balchem in the same industry?

Yes. Both are classified in the Major Chemicals industry within the Industrials sector.

More comparisons